$OMER seeing some articles but I'd be wary only for flips and dips. They have lost most sales but had some nice articles come out over night about their potential pipeline drug that hopes to be FDA fast-tracked.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.